Elzonris ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

elzonris

stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastiske midler - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Mylotarg ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

mylotarg

pfizer europe ma eeig - gemtuzumab ozogamicin - leukæmi, myeloid, akut - antineoplastiske midler - mylotarg er angivet for kombinationsbehandling med daunorubicin (dnr) og cytarabine (arac) til behandling af patienter, alder 15 år og derover med tidligere ubehandlet, de novo cd33-positive akut myeloid leukæmi (aml), bortset fra akut promyelocyt leukæmi (apl).